A Phase 3, Multicenter, Randomized, Double-Masked Clinical Trial to Assess the Efficacy and Safety of Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% Compared to Placebo in the Treatment of Inflammation and Pain Associated With Cataract Surgery
Phase: PHASE3
Conditions: Cataract
Sponsor: Salvat

 
 
 

 
 
 
 
 
 
 
 

 

 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 

- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 

- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 

- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 

- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

 
 
 
 
 

- 
- 
- 
- 
- 

 
 
 
 
 

- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 

- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
 
- 
- 

- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 

- 
- 
- 
- 
- 
- 
- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 

- 
- 
 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 
 

 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 

 
 
 
 
 

 
 

 
 

 
 
 

 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
- 
- 
- 

 

 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

 
 
 
 
 
 
 
 

 
 

- 
- 
- 

- 
- 
 
 

 
 

 
 

 
 
 
 
 
 
 
 
 
 

 
 
 
 
 

- 
- 
 

- 
- 
- 
- 
- 

- 

 
1. 
2. 
3. 
4. 
5. 
6. 
 
 
 
 
7. 
8. 

 
Please assess the severity of the eye discomfort by using the following scale.